메뉴 건너뛰기




Volumn 10, Issue 6, 2008, Pages 486-487

Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

EID: 58149154819     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.v10n0612h     Document Type: Letter
Times cited : (8)

References (11)
  • 1
    • 33749248456 scopus 로고    scopus 로고
    • Children with schizophrenia: Clinical picture and pharmacological treatment
    • Masi G, Mucci M, Pari C. Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs 2006;20(10):841-866
    • (2006) CNS Drugs , vol.20 , Issue.10 , pp. 841-866
    • Masi, G.1    Mucci, M.2    Pari, C.3
  • 2
    • 33745301687 scopus 로고    scopus 로고
    • Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents
    • Jul;
    • Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 2006 Jul;45(7):771-791
    • (2006) J Am Acad Child Adolesc Psychiatry , vol.45 , Issue.7 , pp. 771-791
    • Correll, C.U.1    Carlson, H.E.2
  • 3
    • 1542317468 scopus 로고    scopus 로고
    • Weight gain associated with atypical antipsychotic use in children and adolescents: Prevalence, clinical relevance, and management
    • Stigler KA, Potenza MN, Posey DJ, et al. Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Pediatr Drugs 2004;6(1):33-44
    • (2004) Pediatr Drugs , vol.6 , Issue.1 , pp. 33-44
    • Stigler, K.A.1    Potenza, M.N.2    Posey, D.J.3
  • 4
    • 14844344472 scopus 로고    scopus 로고
    • Metabolic risk during antipsychotic treatment
    • Dec;
    • Newcomer JW. Metabolic risk during antipsychotic treatment. Clin Ther 2004 Dec;26(12):1936-1946
    • (2004) Clin Ther , vol.26 , Issue.12 , pp. 1936-1946
    • Newcomer, J.W.1
  • 5
    • 2542548063 scopus 로고    scopus 로고
    • Obesity and the metabolic syndrome in children and adolescents
    • Jun;
    • Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004 Jun;350(23):2362-2374
    • (2004) N Engl J Med , vol.350 , Issue.23 , pp. 2362-2374
    • Weiss, R.1    Dziura, J.2    Burgert, T.S.3
  • 6
    • 27544479499 scopus 로고    scopus 로고
    • Metabolic side effects of second-generation antipsychotics in children and adolescents: A different story? [ASCP CORNER]
    • Oct;
    • Correll CU. Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story? [ASCP CORNER] J Clin Psychiatry 2005 Oct;66(10):1331-1332
    • (2005) J Clin Psychiatry , vol.66 , Issue.10 , pp. 1331-1332
    • Correll, C.U.1
  • 7
    • 14844286962 scopus 로고    scopus 로고
    • Newer antipsychotic drugs and obesity in children and adolescents: How should we assess drug-associated weight gain?
    • Mar;
    • Vieweg WV, Sood AB, Pandurangi A, et al. Newer antipsychotic drugs and obesity in children and adolescents: how should we assess drug-associated weight gain? Acta Psychiatr Scand 2005 Mar;111(3):177-184
    • (2005) Acta Psychiatr Scand , vol.111 , Issue.3 , pp. 177-184
    • Vieweg, W.V.1    Sood, A.B.2    Pandurangi, A.3
  • 8
    • 28444450241 scopus 로고    scopus 로고
    • Body composition changes associated with second generation antipsychotics
    • Correll CU, Parikh UH, Mughal T. Body composition changes associated with second generation antipsychotics. Biol Psychiatry 2005;57(suppl 8):36
    • (2005) Biol Psychiatry , vol.57 , Issue.SUPPL. 8 , pp. 36
    • Correll, C.U.1    Parikh, U.H.2    Mughal, T.3
  • 9
    • 0033984441 scopus 로고    scopus 로고
    • Historical development and present status of the Schedule for Affective Disorders and Schizophrenia for School Age Children (K-SADS)
    • Jan;
    • Ambrosini PJ. Historical development and present status of the Schedule for Affective Disorders and Schizophrenia for School Age Children (K-SADS). J Am Acad Child Adolesc Psychiatry 2000 Jan;39(1):49-58
    • (2000) J Am Acad Child Adolesc Psychiatry , vol.39 , Issue.1 , pp. 49-58
    • Ambrosini, P.J.1
  • 10
    • 85036898288 scopus 로고    scopus 로고
    • 2000 CDC Growth Charts: United States. Centers for Disease Control, National Center for Health Statistics Web site. Available at: http://www.cdc.gov/growthcharts. Accessibility verified June 13, 2008
    • 2000 CDC Growth Charts: United States. Centers for Disease Control, National Center for Health Statistics Web site. Available at: http://www.cdc.gov/growthcharts. Accessibility verified June 13, 2008
  • 11
    • 33947614732 scopus 로고    scopus 로고
    • An 11-year-old boy with drug resistant schizophrenia treated with temporo-parietal rTMS
    • Apr;
    • Jardri R, Lucas B, Delevoye-Turrell Y, et al. An 11-year-old boy with drug resistant schizophrenia treated with temporo-parietal rTMS. Mol Psychiatry 2007 Apr;12(4):320
    • (2007) Mol Psychiatry , vol.12 , Issue.4 , pp. 320
    • Jardri, R.1    Lucas, B.2    Delevoye-Turrell, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.